Federal health authorities say prescription drugs to help people fight the flu don't appear to be working on a common strain this season.
| Source: The Associated Press
British drugmaker GlaxoSmithKline PLC is moving to expand its vaccine business in the key U.S. market by opening a sprawling East Coast vaccine factory, with production targeted to begin in April.
Merck filed for FDA approval of Gardasil for males ages 9 to 26 in the latter half of last month, CNBC confirmed.
Wednesday, 31 Dec 2008 | Source: The Associated Press
A vice chairman for GlaxoSmithKline in Research Triangle Park is joining the board of directors of Durham-based LED lighting company Cree Inc.
Wednesday, 31 Dec 2008 | Source: The Associated Press
British drugmaker GlaxoSmithKline PLC spent nearly $2 million lobbying the U.S. government on patent laws, drug prices and other issues in the third quarter, according to a recent disclosure form.
Wednesday, 31 Dec 2008 | Source: The Associated Press
Stricter regulation, a dearth of new blockbuster drugs, increased pressure to lower prices and more intense generic competition hammered the pharmaceutical industry in 2008, but its stocks still weathered the market collapse better than many other sectors.
Wednesday, 31 Dec 2008 | Source: The Associated Press
The Food and Drug Administration approved Watson Pharmaceuticals Inc.'s generic version of the nicotine gum Nicorette, the company said Wednesday, and Watson plans to start selling the mint-flavored gum in early January.
Tuesday, 30 Dec 2008 | Source: The Associated Press
Biotech company XenoPort Inc. said Tuesday it received commitments for stock and warrant sales of about $40 million to institutional investors, following a string of drug development setbacks.
Monday, 29 Dec 2008 | Source: The Associated Press
Varian Medical Systems Inc. will hold its annual meeting Feb. 12, 2009, with shareholders voting on four spots on the company's board, along with stock-based compensation issues and incentives for management.
Monday, 22 Dec 2008 | Source: Reuters
GlaxoSmithKline, the world's second biggest drugmaker, on Monday reported positive mid-stage results in key additional indications for its key drug seen as a successor to top-selling Advair.
Tuesday, 16 Dec 2008 | Source: The Associated Press
Drugmaker Bristol-Myers Squibb said Tuesday it will eliminate another 10 percent of its work force through 2010 as it works to pare costs before it loses patent protection on key drugs.
Tuesday, 30 Dec 2008 | Source: The Associated Press
Drug developer GlaxoSmithKline said Tuesday it again extended the tender offer for shares of biotechnology company Genelabs Technologies Inc. and lowered the deal's 90 percent requirement.
Tuesday, 2 Dec 2008 | Source: CNBC.com
A first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome.
The job losses in this downturn are hitting workers across all income levels and job categories, and the cuts are swifter and broader than in past recessions.
The job losses in this downturn are hitting workers across all income levels and job categories, and the cuts are swifter and broader than in past recessions.
Posts |
COMPANY : GlaxoSmithKline plc
23 Dec 2008
Cramer makes the call on viewers' favorite stocks in a special, extended Lightning Round, including PepsiCo, Verizon, Baidu, Boeing and others.... Read More
22 Dec 2008
According to the Center for Responsive Politics, GSK contributed $1.1 million to American political candidates in the 2008 election cycle... Read More
20 Nov 2008
Posted By: CNBC.comCNBC Stock Blog
Telcos, pharmas and some media stocks present investment opportunities now, according to Fergus O'Sullivan, managing director at Morgan Stanley.... Read More
14 Nov 2008
Warren Buffett's Berkshire Hathaway sharply increased its stake in ConocoPhillips this spring and summer, accumulating a total of 84 million shares as of the end of the third quarter on September 30, according to Berkshire's just-released quarterly portfolio filing with the SEC... Read More
14 Nov 2008
The drug company that got into so much trouble when it uncovered and/or disclosed a cardiovascular side-effect of a popular painkiller (Vioxx) is launching a huge study to see if an up-and-coming diabetes drug is also bad for the heart.... Read More
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC MOBILE | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2009 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes